Health5 months ago
Kyverna Therapeutics Announces Phase 2 Trial Results for KYV-101
Kyverna Therapeutics, Inc. has announced plans to present topline results from its registrational Phase 2 clinical trial, known as KYSA-8, assessing the efficacy of its investigational...